Helius Medical Technologies (HSDT) said Wednesday it received a Nasdaq hearings panel notice on Monday that the company has fulfilled compliance with the regulator's equity requirement for continued listing.
The company will be subject to a mandatory panel monitor for one year, effective immediately, Helius said.
Shares of the company were down 2.2% in recent Wednesday trading.
Price: 8.71, Change: -0.20, Percent Change: -2.24
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。